Indications : התוויות

4.1 Therapeutic indications
Oxytocin PANPHARMA should be given with caution to patients with known ‘long QT
Oxytocin PANPHARMA may be used for:                                                              syndrome’ or related symptoms and to patients taking drugs that are known to prolong
• Induction of labour for medical reasons;                                                       the QTc interval (see section 4.5 Interaction with other medicinal products and other
• Stimulation of labour in hypotonic uterine inertia;                                            forms of interaction).
• During Caesarean section following the delivery of the child;                                  When Oxytocin PANPHARMA is given for induction and enhancement of labour:
• Prevention and treatment of postpartum uterine atony and haemorrhage. Oxytocin                 • Foetal distress and foetal death: Administration of oxytocin at excessive doses results in PANPHARMA may also be indicated in early stages of pregnancy as an adjunctive therapy               uterine overstimulation, which may cause foetal distress, asphyxia and death, or may for the management of incomplete, inevitable or missed abortion.                                    lead to hypertonicity, tetanic contractions or rupture of the uterus. Careful monitoring of foetal heart rate and uterine motility (frequency, strength, and duration of contractions)